Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

EGF receptor-related research collaboration with M.D. Anderson announced by Enchira

Oct. 17, 2000

Preparation and use of new TK inhibitors as antiangiogenic agents

Oct. 17, 2000

Interaction regulating apoptosis could impact cancer therapy development

Oct. 17, 2000

Boehringer Ingelheim synthesizes new series of tyrosine kinase inhibitors

Oct. 16, 2000

Strategic collaboration aims to develop new cancer immunotherapies

Oct. 16, 2000

Market launch for Trisenox, a new Rx for a severe form of leukemia

Oct. 16, 2000

Intensive PEG-L-asparaginase regimen improves remission rates in ALL

Oct. 16, 2000

Recent patent covers new approach to managing certain side effects of cancer therapy

Oct. 13, 2000

Series of patents issued to Merck for new protein prenyltransferase inhibitors

Oct. 13, 2000

Engineered prostate cancer-specific virus tested in patients with advanced, metastatic disease

Oct. 13, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...